Zdrowie i gospodarka · 12/10/2011

FDA Hosts Public Workshop to Advance Risk Assessment for Emerging Infectious Diseases Linked to Blood and Blood Products

The US Food and Drug Administration (FDA) is organizing a public workshop to discuss the need for advanced data and risk assessment for emerging infectious diseases affecting blood and blood products, in line with the agency's efforts to enhance the safety and quality of these products.